NCT03068624 2024-01-25Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal MelanomaM.D. Anderson Cancer CenterPhase 1 Unknown34 enrolled